Related Experiment Video
Updated: Jan 20, 2026

Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells
Published on: October 27, 2020
Identification of novel TGF-β regulated genes with pro-migratory roles
Qi Liu1, Nicholas Borcherding2, Peng Shao1
1Department of Anatomy and Cell Biology, Carver College of Medicine, University of Iowa, Iowa City, IA 52242, USA.
Abstract:
Transforming growth factor-β (TGF-β) signaling plays fundamental roles in the development and homeostasis of somatic cells. Dysregulated TGF-β signaling contributes to cancer progression and relapse to therapies by inducing epithelial-to-mesenchymal transition (EMT), enriching cancer stem cells, and promoting immunosuppression. Although many TGF-β-regulated genes have been identified, only a few datasets were obtained by next-generation sequencing. In this study, we performed RNA-sequencing analysis of MCF10A cells and identified 1166 genes that were upregulated and 861 genes that were downregulated by TGF-β. Gene set enrichment analysis revealed that focal adhesion and metabolic pathways were the top enriched pathways of the up- and downregulated genes, respectively. Genes in these pathways also possess significant predictive value for renal cancers. Moreover, we confirmed that TGF-β induced expression of MICAL1 and 2, and the histone demethylase, KDM7A, and revealed their regulatory roles on TGF-β-induced cell migration. We also show a critical effect of KDM7A in regulating the acetylation of H3K27 on TGF-β-induced genes. In sum, this study identified novel effectors that mediate the pro-migratory role of TGF-β signaling, paving the way for future studies that investigate the function of MICAL family members in cancer and the novel epigenetic mechanisms downstream TGF-β signaling.
Insights
Transforming growth factor-beta (TGF-β) signaling impacts cell development and cancer. This study used RNA-sequencing to identify novel genes and epigenetic mechanisms, like KDM7A, involved in TGF-β-driven cell migration and cancer progression.
Area of Science:
- Cell Biology
- Molecular Biology
- Cancer Research
Background:
- Transforming growth factor-beta (TGF-β) signaling is crucial for cell development and homeostasis.
- Dysregulated TGF-β signaling contributes to cancer progression, epithelial-to-mesenchymal transition (EMT), cancer stem cell enrichment, and immunosuppression.
- Limited next-generation sequencing datasets exist for TGF-β-regulated genes.
Purpose of the Study:
- To identify novel genes and pathways regulated by TGF-β using RNA-sequencing.
- To investigate the role of identified genes and epigenetic modifications in TGF-β-induced cell migration.
- To explore the potential of these findings in understanding cancer progression and therapeutic relapse.
Main Methods:
- RNA-sequencing analysis of MCF10A cells treated with TGF-β.
- Gene set enrichment analysis to identify enriched pathways.
- Confirmation of gene expression and functional assays for cell migration.
- Analysis of epigenetic modifications, specifically H3K27 acetylation.
Main Results:
- Identified 1166 upregulated and 861 downregulated genes in response to TGF-β.
- Focal adhesion and metabolic pathways were top enriched pathways for up- and downregulated genes, respectively.
- TGF-β induced expression of MICAL1, MICAL2, and KDM7A, which regulate cell migration.
- KDM7A critically affects H3K27 acetylation on TGF-β-induced genes.
Conclusions:
- This study identified novel effectors, including MICAL family members and KDM7A, mediating TGF-β's pro-migratory role.
- Revealed novel epigenetic mechanisms, specifically KDM7A's role in H3K27 acetylation, downstream of TGF-β signaling.
- These findings provide a basis for future research into MICAL family functions in cancer and TGF-β-mediated epigenetic regulation.
Related Concept Videos
TGF - β Signaling Pathway
Gene Regulation During Sporulation
Circadian Rhythms and Gene Regulation
Constitutive and Regulated Gene Expression
Cell Specific Gene Expression
Epigenetic Regulation

